Louise’s interests are focused on product discovery and development for tropical diseases, particularly neglected tropical diseases (NTDs) and malaria.
Louise graduated with a BSc (Hons) in Applied Biology (University of Leeds) and a MSc in Applied Parasitology and Medical Entomology (University of Liverpool). She began her research career as a research assistant at the University of Durham, after which she joined the Liverpool School of Tropical Medicine completing a PhD on the role of Wolbachia in the immune response to filariasis. Louise then moved to the New York Blood Center to work as a post-doctoral research fellow with Dr Sara Lustigman to identify potential filarial drug and vaccine candidates.
In 2007 Louise rejoined LSTM where she worked for over 10 years on the Anti-Wolbachia (A·WOL) Drug Discovery & Development Programme, headed by Prof Mark Taylor and funded through the Bill and Melinda Gates Foundation. This was followed by a 1-year post within LSTMs Centre for Drugs and Diagnostics Research managing projects working on diagnostics for Visceral Leishmaniasis in the Indian Sub-Continent.
Louise joined LITE (Liverpool Insect Testing Establishment), a client-based facility which rears multiple strains of mosquitoes (susceptible & resistant) and performs bioassays to evaluate the sensitivity to insecticides and novel chemistries, in 2019. As a study director she is responsible for insectary management & bioassay testing.
Louise has a wide-range of expertise in laboratory-based research, scientific communication, teaching, public engagement (STEM ambassador), and project management. She is an author on 35 peer-reviewed publications, 2 book chapters, and 1 patent.